Outcomes and clinical predictors of extracorporeal shock wave therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome: a prospective randomized double-blind placebo-controlled clinical trial

被引：0

作者：

Ahmed M. Sakr

Amr M. Fawzi

Mostafa Kamel

Maged M. Ali

机构：

[1] Zagazig University,Urology Department, Faculty of Medicine

来源：

Prostate Cancer and Prostatic Diseases | 2022年 / 25卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：93 / 99

页数：6

共 50 条

[21] Re: The Efficacy and Safety of Serenoa Repens Extract for the Treatment of Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Cadeddu, Jeffrey A.
[J]. JOURNAL OF UROLOGY, 2022, 208 (06): : 1330 - 1331
[22] A RANDOMIZED PLACEBO-CONTROLLED MULTICENTER TRIAL OF PREGABALIN FOR THE TREATMENT OF MEN WITH CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME
Pontari, Michel A.
Krieger, John N.
Litwin, Mark S.
White, Paige C.
Anderson, Rodney U.
McNaughton-Collins, Mary
Nickel, J. Curtis
Shoskes, Daniel A.
Alexander, Richard B.
Nadler, Robert B.
O'Leary, Michael P.
Zeitlin, Scott
Chuai, Shannon
Landis, J. Richard
Kusek, John W.
Nyberg, Leroy M.
Schaeffer, Anthony J.
[J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 123 - 123
[23] A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Of Omalizumab For Chronic Rhinosinusitis
Mehta, N. J.
Pinto, J.
de Tineo, M.
Baroody, F. M.
Naclerio, R. M.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S201 - S201
[24] Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: A randomized double blind trial
Nickel, JC
Narayan, P
McKay, J
Doyle, C
[J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 1594 - 1597
[25] Editorial Comment on: A First Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Extracorporeal Shock Wave Therapy for the Treatment of Peyronie's Disease
Morales, Antonio Martin
[J]. EUROPEAN UROLOGY, 2009, 56 (02) : 369 - 370
[26] Extracorporeal Shock Wave Therapy for the Treatment of Chronic Pelvic Pain Syndrome in Males: A Randomised, Double-Blind, Placebo-Controlled Study (vol 56, pg 418, 2009)
Zimmermann, Reinhold
Cumpanas, Alin
Miclea, Florin
Janetschek, Guenter
[J]. EUROPEAN UROLOGY, 2020, 77 (05) : E140 - E140
[27] Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome: results of a prospective pilot double-blind and randomized placebo-controlled study
Falahatkar, Siavash
Shahab, Elaheh
Moghaddam, Keivan Gholamjani
Kazemnezhad, Ehsan
[J]. BJU INTERNATIONAL, 2015, 116 (04) : 641 - 649
[28] Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial
Motamed, Mahsa
Karimi, Hanieh
Moghaddam, Hossein Sanjari
Boroujeni, Sina Taherzadeh
Sanatian, Zahra
Hasanzadeh, Alireza
Ardakani, Mohammad-Reza Khodaei
Akhondzadeh, Shahin
[J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2022, 37 (03) : 92 - 101
[29] IMMUNOSTIMULATION IN CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME (CP/CPPS). A ONE-YEAR PROSPECTIVE, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Wagenlehner, Florian
Ballarini, Stefania
Naber, Kurt
[J]. JOURNAL OF UROLOGY, 2014, 191 (04): : E154 - E154
[30] Immunostimulation in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a one-year prospective, double-blind, placebo-controlled study
Wagenlehner, Florian M. E.
Ballarini, Stefania
Naber, Kurt G.
[J]. WORLD JOURNAL OF UROLOGY, 2014, 32 (06) : 1595 - 1603

← 1 2 3 4 5 →